Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 98
Filter
1.
Mycotoxin Res ; 40(2): 269-277, 2024 May.
Article in English | MEDLINE | ID: mdl-38421516

ABSTRACT

This experiment was conducted to determine the effect of an adsorbent material based on powdered alfalfa leaves added in the aflatoxin B1 (AFB1)-contaminated diet of turkey poults on production parameters, blood cell count, serum biochemistry, liver enzymes, and liver histology. For this purpose, three hundred and fifty female Nicholas-700 poults were randomly assigned into five treatments: (1) Control, AFB1-free diet; (2) AF, diet contaminated with 250 ng AFB1/g; (3) Alfalfa, AFB1-free diet + 0.5% (w/w) adsorbent; (4) AF+alfalfa, diet contaminated with 250 ng AFB1/g + 0.5% (w/w) adsorbent, and (5) AF+ yeast cell wall (YCW), diet contaminated with 250 ng AFB1/g + 0.5% (w/w) of yeast cell wall (a commercial mycotoxin binder used as reference material). The in vivo efficacy of powdered alfalfa leaves was assessed during a 28-day period. In general, the addition of powdered alfalfa leaves in the AFB1-free diet gave the best performance results (body weight, body weight gain, and feed intake) and improved the values of total protein, glucose, calcium, creatinine, and blood urea nitrogen. Moreover, the addition of powdered alfalfa leaves in the AFB1-contaminated diet enhanced body weight and body weight gain and significantly reduced the feed intake, compared to the AF and AF+YCW groups. Additionally, significant alterations in serum parameters were observed in poults intoxicated with the AFB1, compared to the Control group. Furthermore, typical histopathological lesions were observed in the liver of the AF group, which were significantly ameliorated with the addition of powdered alfalfa leaves. Conclusively, these results pointed out that low inclusion of powdered alfalfa leaves in the contaminated feed counteracted the adverse effects of AFB1 in turkey poults.


Subject(s)
Aflatoxin B1 , Animal Feed , Medicago sativa , Plant Leaves , Turkeys , Animals , Aflatoxin B1/toxicity , Medicago sativa/chemistry , Plant Leaves/chemistry , Animal Feed/analysis , Female , Liver/drug effects , Liver/pathology , Diet/veterinary , Powders , Body Weight/drug effects
2.
Med Intensiva (Engl Ed) ; 44(6): 371-388, 2020.
Article in English, Spanish | MEDLINE | ID: mdl-32360034

ABSTRACT

On March 11, 2020, the Director-General of the World Health Organization (WHO) declared the disease caused by SARS-CoV-2 (COVID-19) as a pandemic. The spread and evolution of the pandemic is overwhelming the healthcare systems of dozens of countries and has led to a myriad of opinion papers, contingency plans, case series and emerging trials. Covering all this literature is complex. Briefly and synthetically, in line with the previous recommendations of the Working Groups, the Spanish Society of Intensive, Critical Medicine and Coronary Units (SEMICYUC) has prepared this series of basic recommendations for patient care in the context of the pandemic.


Subject(s)
Betacoronavirus , Coronavirus Infections/therapy , Critical Care/standards , Pneumonia, Viral/therapy , Societies, Medical , Adult , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Critical Care/methods , Critical Illness/epidemiology , Critical Illness/therapy , Delivery of Health Care/methods , Delivery of Health Care/standards , Disease Management , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , SARS-CoV-2 , Spain/epidemiology
3.
Mycotoxin Res ; 36(1): 31-39, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31297722

ABSTRACT

The effect of dietary aflatoxin B1 (AFB1) and Salmonella Enteritidis infection on intestinal permeability was investigated. Two hundred 1-day-old male Ross 308 broiler chickens were randomly divided into 4 treatments of 5 replicates each (10 birds per replicate), which were fed ad libitum for 3 weeks with the following treatments: control, chickens fed an AFB1-free diet; AF, chickens fed an AFB1-contaminated diet at 470 ng/g; SE, chickens fed an AFB1-free diet and challenged with 108 cfu of S. Enteritidis per bird at 18 days old; AF + SE, chickens fed an AFB1-contaminated diet and challenged with 108 cfu of S. Enteritidis per bird at 18 days old. At day 21 of age, chicks received an oral gavage dose of fluorescein isothiocyanate dextran (FITC-dextran) to evaluate gastrointestinal leakage. Blood and intestinal samples were collected to evaluate serum biochemistry and total intestinal IgA secretion, respectively. Liver tissues were aseptically collected to assess bacterial invasiveness and for histomorphological studies. The results showed that chickens receiving AFB1 presented a significant increment (up to 2.4-fold) in serum FITC-dextran concentration (p < 0.05). Nevertheless, S. Enteritidis infection had no additional effect on gastrointestinal leakage. Furthermore, the ingestion of AFB1 had no impact on the invasive potential of S. Enteritidis. These results suggest that moderate-dose AFB1 adversely affects intestinal barrier function resulting in increased gut permeability in broiler chickens.


Subject(s)
Aflatoxin B1 , Intestines/pathology , Permeability/drug effects , Salmonella enteritidis/pathogenicity , Aflatoxin B1/administration & dosage , Aflatoxin B1/adverse effects , Aflatoxin B1/toxicity , Animal Feed/analysis , Animals , Chickens , Diet/veterinary , Liver/drug effects , Liver/microbiology , Liver/pathology , Poultry Diseases , Salmonella Infections, Animal
4.
Med Oral Patol Oral Cir Bucal ; 24(5): e595-e602, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31433394

ABSTRACT

BACKGROUND: The aim of the present study was to describe and compare the oral and dental health status of two groups, one diagnosed with eating disorders (EDs), and another group without this pathology, assessing the following oral manifestations: dental alterations, periodontal disorders, soft tissue disorders, non-stimulated salivary flow, and oral pH. MATERIAL AND METHODS: This comparative transversal epidemiological study included 179 participants, of whom 59 were diagnosed with EDs (Eating Disorder Group: EDG) and 120 had no antecedents of EDs (No Eating Disorder Group: NEDG). All patients fulfilled the following inclusion criteria: women aged over 18 years, diagnosed with an ED by a specialist, patients who had undergone at least 1 year monitoring by the Clinical Nutrition Unit, and had not received any periodontal treatment during the previous 6 months. Both groups were homogeneous in terms of sex, age, education, and socioeconomic level. Oral exploration was performed, registering clinical variables, as well as sociodemographic and socioeconomic data, oral hygiene habits, and smoking. Statistical significance was established as p<0.05 (confidence level > 95%). RESULTS: The dental erosion (DE) was the most significative feature of dental alterations. The degree of DE was significantly greater in the EDG (p<0.001). A significant association between soft tissue lesions and EDs was found (p<0.001) A notable difference in non-stimulated salivary flow was found between the groups (p<0.001). No significant differences between the groups were found for periodontal status, dental caries, or oral hygiene practices. CONCLUSIONS: On the basis of the results obtained, it is necessary to carry out oral/dental examination as soon as an ED is diagnosed with regular check-ups thereafter.


Subject(s)
Dental Caries , Feeding and Eating Disorders , Adolescent , Adult , Female , Health Status , Humans , Middle Aged , Oral Health , Spain
6.
Ann Hematol ; 96(8): 1323-1330, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28536895

ABSTRACT

Guidelines recommend autologous stem cell transplantation (ASCT) consolidation in first complete or partial response after regimens including rituximab (R) and high-dose AraC (HDAC), but its use beyond that response is questioned. We present a retrospective analysis of 268 patients with MCL who received ASCT. With a median follow-up for survival patients of 54 months, progression-free survival and overall survival for the whole series were 38 and 74 months, respectively, and for patients transplanted in first CR 49 and 97 months, respectively. Patients without CR before transplant were analyzed separately, those who achieved CR after transplantation had better PFS (48 vs 0.03 months, p < 0.001) and OS (92 vs 16 months, p < 0.001) than the remaining. In univariate analysis, first CR at transplant (p = 0.01) and prior rituximab (p = 0.02) were the variables associated with PFS. For OS, the same variables resulted significant (p = 0.03 and p < 0.001, respectively). In multivariate analysis, only the status at transplant (first CR) remained significant. This retrospective study concludes that ASCT consolidation in first CR induces high survival rates. In other stages of disease, the need of ASCT as consolidation may be questioned.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Hematopoietic Stem Cell Transplantation/methods , Lymphoma, Mantle-Cell/therapy , Adult , Aged , Cytarabine/administration & dosage , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Multivariate Analysis , Outcome Assessment, Health Care/methods , Outcome Assessment, Health Care/statistics & numerical data , Proportional Hazards Models , Remission Induction , Retrospective Studies , Rituximab/administration & dosage , Transplantation Conditioning , Transplantation, Autologous , Young Adult
7.
J Evol Biol ; 30(4): 814-825, 2017 04.
Article in English | MEDLINE | ID: mdl-28181330

ABSTRACT

Many palaeontological studies have investigated the evolution of entire body plans, generally relying on discrete character-taxon matrices. In contrast, macroevolutionary studies performed by neontologists have mostly focused on morphometric traits. Although these data types are very different, some studies have suggested that they capture common patterns. Nonetheless, the tests employed to support this claim have not explicitly incorporated a phylogenetic framework and may therefore be susceptible to confounding effects due to the presence of common phylogenetic structure. We address this question using the scorpion genus Brachistosternus Pocock 1893 as case study. We make use of a time-calibrated multilocus molecular phylogeny, and compile discrete and traditional morphometric data sets, both capturing the overall morphology of the organisms. We find that morphospaces derived from these matrices are significantly different, and that the degree of discordance cannot be replicated by simulations of random character evolution. Moreover, we find strong support for contrasting modes of evolution, with discrete characters being congruent with an 'early burst' scenario whereas morphometric traits suggest species-specific adaptations to have driven morphological evolution. The inferred macroevolutionary dynamics are therefore contingent on the choice of character type. Finally, we confirm that metrics of correlation fail to detect these profound differences given common phylogenetic structure in both data sets, and that methods incorporating a phylogenetic framework and accounting for expected covariance should be favoured.


Subject(s)
Biological Evolution , Phylogeny , Scorpions , Animals , Phenotype , Species Specificity
8.
Med Intensiva ; 38(1): 11-20, 2014.
Article in Spanish | MEDLINE | ID: mdl-23909987

ABSTRACT

OBJECTIVES: To evaluate the effects of the early administration of statins during acute myocardial infarction (MI). DESIGN: A retrospective cohort study was carried out. SETTING: National (Spain). PATIENTS OR PARTICIPANTS: Patients included in the ARIAM registry from January 1999 to December 2008 with a diagnosis of MI. INTERVENTIONS: None. MAIN VARIABLES: We used logistic regression analysis and propensity scoring to determine whether the administration of statins during the first 24h of MI acts as a protective factor against: 1) mortality, 2) the incidence of lethal arrhythmias, or 3) cardiogenic shock. RESULTS: A total of 36 842 patients were included in the study. Statins were administered early in 50.2% of the patients. Statin administration was associated with younger patients with known previous dyslipidemia, obesity, a history of ischemic heart disease, heart failure, presence of sinus tachycardia, use of beta-blockers, angiotensin-converting enzyme inhibitors, thrombolysis and percutaneous coronary intervention. Mortality was 8.2% (13.2% without statin versus 3% with statin, P<.001). Multivariate analysis demonstrated that statin administration acted as a protective factor against mortality (adjusted OR 0.518, 95%CI 0.447 to 0.601). Continued use of statins was associated with a reduction in mortality (adjusted OR 0.597, 95%CI 0.449 to 0.798), and the start of treatment was a protective factor against mortality (adjusted OR 0.642, 95%CI 0.544 -0.757). Statin therapy also exerted a protective effect against the incidence of lethal arrhythmias and cardiogenic shock. CONCLUSIONS: These results suggest that early treatment with statins in patients with MI is associated with reduced mortality.


Subject(s)
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Myocardial Infarction/drug therapy , Cohort Studies , Female , Humans , Male , Retrospective Studies , Secondary Prevention
9.
Neuropharmacology ; 70: 190-9, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23168115

ABSTRACT

Unraveling the mechanisms of 5-HT neuron control might provide new insights into depression pathophysiology. In addition to the inhibitory 5-HT1A autoreceptors, cortico-raphe glutamatergic descending pathways are suggested to modulate 5-HT activity in the DRN. Here we studied how decreased VGLUT1 levels in the brain stem affect glutamate regulation of 5-HT function. VGLUT1+/- mice (C57BL/6) and wild type (WT) littermates were used. VGLUT1 expression in the DRN, 5-HT turnover and immuno histochemical analysis of neuronal activity in different areas was studied. Moreover, the functionality of the inhibitory 5-HT1A autoreceptor was assessed using electrophysiological, biochemical and pharmacological approaches. VGLUT1 immunoreactivity was markedly lower in the DRN of the VGLUT1+/- mice and specifically, in the surroundings of GABA and 5-HT cell bodies. These mice showed decreased induced neuronal activity in 5-HT cells bodies and in different forebrain areas, as well as decreased hippocampal cell proliferation and 5-HT turnover. Further, 5-HT1A autoreceptor desensitization was evidenced by electrophysiological studies, GTP-γ-S coupling to 5-HT1A autoreceptor and a lower hypothermic response to 5-HT1A activation. This study shows first time that VGLUT1 dependent glutamate innervation of the DRN could modulate 5-HT function.


Subject(s)
Glutamic Acid/physiology , Raphe Nuclei/metabolism , Receptor, Serotonin, 5-HT1A/physiology , Serotonin/metabolism , Vesicular Glutamate Transport Protein 1/biosynthesis , Animals , Autoreceptors/physiology , Brain Stem/metabolism , Cell Proliferation , Gene Expression/genetics , Hippocampus/physiology , Hypothermia/physiopathology , Male , Mice , Neurons/metabolism , Signal Transduction/physiology , Vesicular Glutamate Transport Protein 1/genetics
10.
J Neuroendocrinol ; 25(4): 350-6, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23181759

ABSTRACT

It is becoming evident that chronic exposure to glucocorticoids might not only result in insulin resistance or cognitive deficits, but also is considered as a risk factor for pathologies such as depression or Alzheimer's disease. In the present study, in vivo experiments using a non-invasive method of chronic administration of corticosterone in drinking water demonstrated that chronic corticosterone administration led to cognitive impairment in the novel object recognition test and insulin resistance, as shown by significant increases in plasma insulin levels and the homeostatic model assessment index, and decreased insulin receptor phosphorylation. Corticosterone treatment induced an increased expression of stress-activated c-Jun N-terminal kinase (JNK) in the hippocampus, accompanied by decreases in glycogen synthase kinase 3ß, increases in pTau levels and increased neuronal cell death (caspase-3 activity). All these effects were reversed by the administration of a JNK1 inhibitor or by the mineralocorticoid receptor antagonist spironolactone. It is suggested that the mineralocorticoid receptors and JNK-mediated pathways are involved in the interaction of glucocorticoid-insulin resistance and the development of relevant cellular processes for Alzheimer's disease.


Subject(s)
Cognition Disorders/chemically induced , Corticosterone/administration & dosage , Insulin Resistance , JNK Mitogen-Activated Protein Kinases/metabolism , Receptors, Mineralocorticoid/metabolism , Animals , Corticosterone/adverse effects , Insulin/blood , Male , Mice , Mice, Inbred C57BL
11.
J Neuroendocrinol ; 23(4): 329-44, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21219484

ABSTRACT

We have analysed the long-term psychoneuroendocrine effects of maternal deprivation (MD) [24 h at postnatal day (PND) 9] and/or exposure to chronic unpredictable stress (CUS) during the periadolescent period (PND 28 to PND 43) in male and female Wistar rats. Animals were tested in the elevated plus maze (EPM, anxiety) at PND 44 and in two memory tests, spontaneous alternation and novel object recognition (NOT) in adulthood. The expression of hippocampal glucocorticoid (GR) and mineralocorticoid (MR) receptors, as well as of synaptophysin, neural cell adhesion molecule and brain-derived neurotrophic factor, was analysed by in situ hybridisation in selected hippocampal regions. Endocrine determinations of leptin, testosterone and oestradiol plasma levels were carried out by radioimmunoassay. Young CUS animals showed decreased anxiety behaviour in the EPM (increased percentage of time and entries in the open arms) irrespective of neonatal treatment. Memory impairments were induced by the two stressful treatments as was revealed by the NOT, with males being most clearly affected. Although each stressful procedure, when considered separately, induced different (always decrements) effects on the three synaptic molecules analysed and affected males and females differently, the combination of MD and CUS induced an unique disruptive effect on the three synaptic plasticity players. MD induced a long-term significant decrease in hippocampal GR only in males, whereas CUS tended to increase MR in males and decrease MR in females. Both neonatal MD and periadolescent CUS induced marked reductions in testosterone and oestradiol in males, whereas MD male animals also showed significantly decreased leptin levels. By contrast, in females, none of the hormones analysed was altered by any of the stressful procedures. Taking our data together in support of the 'two-hit' hypothesis, MD during neonatal life and/or exposure to CUS during the periadolescent period induced a permanent deficit in memory, which was accompanied by a decrement in markers for hippocampal plasticity. The long-term effects on body weight and hormone levels, particularly among males, might reflect sex-dependent lasting metabolic alterations as well as an impaired reproductive function.


Subject(s)
Maternal Deprivation , Stress, Physiological , Stress, Psychological , Animals , Anxiety/physiopathology , Behavior, Animal , Estradiol/blood , Female , Hippocampus/cytology , Hippocampus/metabolism , Leptin/blood , Male , Maze Learning , Neural Cell Adhesion Molecules/genetics , Neural Cell Adhesion Molecules/metabolism , Neuronal Plasticity/physiology , Neuropsychological Tests , Rats , Rats, Wistar , Receptors, Glucocorticoid/genetics , Receptors, Glucocorticoid/metabolism , Receptors, Mineralocorticoid/genetics , Receptors, Mineralocorticoid/metabolism , Synaptophysin/genetics , Synaptophysin/metabolism , Testosterone/blood
12.
Eur Neuropsychopharmacol ; 21(1): 23-32, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20937555

ABSTRACT

Major depression might originate from both environmental and genetic risk factors. The environmental chronic mild stress (CMS) model mimics some environmental factors contributing to human depression and induces anhedonia and helplessness. Mice heterozygous for the synaptic vesicle protein (SVP) vesicular glutamate transporter 1 (VGLUT1) have been proposed as a genetic model of deficient glutamate function linked to depressive-like behaviour. Here, we aimed to identify, in these two experimental models, gene expression changes in the frontal cortex, common to stress and impaired glutamate function. Both VGLUT1(+/-) and CMS mice showed helpless and anhedonic-like behavior. Microarray studies in VGLUT1(+/-) mice revealed regulation of genes involved in apoptosis, neurogenesis, synaptic transmission, protein metabolic process or learning and memory. In addition, RT-PCR studies confirmed gene expression changes in several glutamate, GABA, dopamine and serotonin neurotransmitter receptors. On the other hand, CMS affected the regulation of 147 transcripts, some of them involved in response to stress and oxidoreductase activity. Interestingly, 52 genes were similarly regulated in both models. Specifically, a dowregulation in genes that promote cell proliferation (Anapc7), cell growth (CsnK1g1), cell survival (Hdac3), and inhibition of apoptosis (Dido1) was observed. Genes linked to cytoskeleton (Hspg2, Invs), psychiatric disorders (Grin1, MapK12) or an antioxidant enzyme (Gpx2) were also downregulated. Moreover, genes that inhibit the MAPK pathways (Dusp14), stimulate oxidative metabolism (Eif4a2) and enhance glutamate transmission (Rab8b) were upregulated. We suggest that these genes could form part of the altered "molecular context" underlying depressive-like behaviour in animal models. The clinical relevance of these findings is discussed.


Subject(s)
Depression/genetics , Depressive Disorder/genetics , Frontal Lobe/metabolism , Glutamic Acid/genetics , Stress, Psychological/genetics , Vesicular Glutamate Transport Protein 1/genetics , Animals , Behavior, Animal , Depression/physiopathology , Depressive Disorder/metabolism , Disease Models, Animal , Gene Expression Profiling , Gene Expression Regulation , Glutamic Acid/metabolism , Humans , Male , Mice , Mice, Inbred C57BL , Microarray Analysis , Mood Disorders/genetics , Neurotransmitter Agents/genetics , Neurotransmitter Agents/metabolism , Phenotype , Pleasure , RNA/analysis , Stress, Psychological/metabolism , Sucrose , Time Factors , Vesicular Glutamate Transport Protein 1/deficiency , Vesicular Glutamate Transport Protein 1/metabolism
13.
J Dairy Sci ; 93(7): 3056-64, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20630222

ABSTRACT

The single-dose disposition kinetics of difloxacin were determined in clinically normal lactating goats (n=6) after intravenous (IV) and subcutaneous (SC) administration and subcutaneous administration of a long-acting poloxamer 407 gel formulation (P407). Difloxacin concentrations were determined by HPLC with fluorescence detection. Minimum inhibitory concentrations of difloxacin against 14 strains of Staphylococcus aureus isolated from mastitic goats' milk in Spain were determined to compute pharmacodynamic surrogate markers. The concentration-time data were analyzed by compartmental and noncompartmental pharmacokinetic methods. Following SC and P407 administration, difloxacin achieved maximum milk concentrations of 1.34+/-0.12 and 2.97+/-1.18 mg/L, respectively, at 4.00+/-0.00 h (SC) and 3.60+/-0.89 h (P407) after administration. The absolute bioavailabilities after SC and P407 administration were 81.74+/-15.60% and 72.58+/-20.45%, respectively. Difloxacin penetration from the blood into the milk was good and high concentrations were found in milk secretions. From these data, a 15 mg/kg dose of difloxacin P407 would appear to be effective against Staphylococcus aureus isolated from mastitic goats' milk with minimum inhibitory concentrations

Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Ciprofloxacin/analogs & derivatives , Infusions, Subcutaneous , Milk/chemistry , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/analysis , Ciprofloxacin/administration & dosage , Ciprofloxacin/analysis , Ciprofloxacin/pharmacokinetics , Female , Goats , Infusions, Intravenous , Microbial Sensitivity Tests , Milk/microbiology , Spain , Staphylococcus aureus/drug effects
14.
Ann Oncol ; 21(9): 1891-1897, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20231299

ABSTRACT

BACKGROUND: We have investigated if rituximab-based salvage regimens improve response rates and survival of patients with diffuse large B-cell lymphoma (DLBCL) relapsing after an autologous stem-cell transplantation (ASCT). PATIENTS AND METHODS: We have retrospectively analyzed 82 patients with DLBCL who received salvage therapy for relapse or progression after ASCT. Patients were divided into two groups, according to whether rituximab-based salvage regimens were given (n = 42, 'R-' group) or not (n = 40, 'R+' group) after ASCT. RESULTS: Patients in the R+ group had better complete remission (CR) (55% versus 21.4%, P = 0.006) and overall response (OR) (75% versus 40.4%, P = 0.001) rates, and better 3-year event-free survival (EFS) (37% versus 9%, P = 0.002) and overall survival (OS) (50% versus 20%, P = 0.005) than patients in the R- group. Patients retreated with rituximab had better CR (42.9% versus 21.4%, P = 0.032) and OR (66.7% versus 40.4%, P = 0.019) rates, and better OS (36.2% versus 20% at 3 years, P = 0.05) and EFS (36.2% versus 9% at 3 years, P = 0.05) than patients who received chemotherapy alone at relapse after ASCT. CONCLUSIONS: The addition of rituximab to salvage chemotherapy improves response rates and EFS in patients with relapsed DLBCL after ASCT. These patients may benefit from rituximab retreatment, although larger prospective studies are needed to confirm these results.


Subject(s)
Antibodies, Monoclonal, Murine-Derived/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Lymphoma, Large B-Cell, Diffuse/therapy , Neoplasm Recurrence, Local/drug therapy , Salvage Therapy , Stem Cell Transplantation/adverse effects , Adolescent , Adult , Aged , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Middle Aged , Neoplasm Recurrence, Local/diagnosis , Neoplasm Staging , Remission Induction , Retrospective Studies , Rituximab , Survival Rate , Transplantation, Autologous , Treatment Outcome , Young Adult
15.
Clín. investig. ginecol. obstet. (Ed. impr.) ; 35(6): 231-234, nov. 2008. ilus
Article in Es | IBECS | ID: ibc-70373

ABSTRACT

Ante el hallazgo ecográfico prenatal de una masa quística suprarrenal se debe hacer un exhaustivo diagnóstico diferencial. Éste incluye procesos benignos, como la hemorragia suprarrenal, quistes renales, secuestros pulmonares, malformaciones adenomatosas pulmonares, quistes mesentéricos y retroperitoneales, y duplicaciones entéricas, y también se tienen que descartar tumores malignos, como el neuroblastoma y el nefroblastoma mesoblástico congénito. El mayor problema de diagnóstico diferencial se presenta entre la hemorragia suprarrenal, que generalmente es un proceso regresivo, con ausencia de vasos en el estudio Doppler color, y el neuroblastoma, que permanece estableo puede ser expansivo, demostrándose con el Doppler color la presencia de vasos intratumorales (AU)


When an adrenal cystic mass is detected on prenatals onography, a differential diagnosis must be made, which should include benign lesions – such as adrenal hemorrhage, simple renal cyst, extralobar pulmonary sequestration, pulmonary cystic adenomatoid malformation,enteric duplication cyst, mesenteric and retroperitonealcyst – and malignant tumors, such as neuroblastoma and congenital mesoblastic nephroblastoma. The main difficulty is to differentiate between adrenal hemorrhage, which is usually a regressive process and shows the absence of vessels on color Doppler sonography, and neuroblastoma, which remains stable ormay grow and shows vessels that invade the tumor on color Doppler sonography (AU)


Subject(s)
Humans , Female , Adult , Adrenal Gland Neoplasms/complications , Prenatal Diagnosis/methods , Diagnosis, Differential , Pregnancy Complications/diagnosis , Pregnancy Complications/therapy , Norepinephrine/therapeutic use , Vanilmandelic Acid/therapeutic use , Neuroblastoma/complications , Neuroblastoma/diagnosis , Adrenal Cortex Neoplasms/pathology , Adrenal Cortex Neoplasms/surgery , Adrenal Cortex Neoplasms
16.
Br J Pharmacol ; 155(3): 434-40, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18622410

ABSTRACT

BACKGROUND AND PURPOSE: The beneficial effect of 5-HT6 receptor antagonism in cognition remains controversial. This study has been undertaken to reassess the cognition enhancing properties of acute vs subchronic treatment with the selective 5-HT6 receptor antagonist SB-271046 in unimpaired rats, as well as against scopolamine (cholinergic-) or MK-801 (glutamatergic-mediated) deficits. EXPERIMENTAL APPROACH: The Morris water maze was used, measuring behaviour acquisition and retention, and swim speed. Other behavioural measures included yawning and motor activity. SB-271046 was given acutely before each trial or subchronically for 7 days before the trials. The AChE inhibitor galanthamine was also used alone or in combination with SB-271046. KEY RESULTS: Subchronic treatment with SB-271046 improved acquisition in the Morris water maze, while the acute treatment only improved retention. Neither acute nor subchronic SB-271046 treatment reversed scopolamine-induced learning deficits. MK-801 induced learning impairment associated with a behavioural syndrome, reversed by acute, but not subchronic, SB-271046 treatment. Interestingly, combined treatment with galanthamine and SB-271046 reversed the scopolamine- or MK-801-induced learning impairments. Subchronic treatment with SB-271046 did not modify motor activity or the increased number of yawns, a cholinergic-mediated behaviour, induced by single administration of SB-271046. CONCLUSIONS AND IMPLICATIONS: These data suggest a potential therapeutic role of 5-HT6 receptor antagonists such as SB-271046, alone or in combination with galanthamine, in the treatment of cognitive dysfunction, such as those seen in Alzheimer's disease and schizophrenia.


Subject(s)
Cognition Disorders/drug therapy , Maze Learning/drug effects , Receptors, Serotonin/drug effects , Serotonin Antagonists/pharmacology , Sulfonamides/pharmacology , Thiophenes/pharmacology , Animals , Cholinesterase Inhibitors/pharmacology , Cognition Disorders/physiopathology , Disease Models, Animal , Dizocilpine Maleate/pharmacology , Drug Administration Schedule , Drug Therapy, Combination , Galantamine/pharmacology , Male , Motor Activity/drug effects , Rats , Rats, Wistar , Receptors, Serotonin/metabolism , Scopolamine/pharmacology , Serotonin Antagonists/administration & dosage , Sulfonamides/administration & dosage , Thiophenes/administration & dosage , Yawning/drug effects
17.
Neuroscience ; 154(4): 1218-26, 2008 Jul 17.
Article in English | MEDLINE | ID: mdl-18554808

ABSTRACT

We studied the long term effects of neonatal stress in female rats and subsequent responses to stress when adults. Female rats that experienced maternal separation (MS) showed in adulthood depressive-like behavior in the forced swimming test and cognitive impairments in the novel object recognition test, which were reverted by the glucocorticoid receptor antagonist mifepristone or the beta-adrenoceptor antagonist propranolol. Markers of HPA axis (corticosterone levels, CRF mRNA levels in the paraventricular nucleus and glucocorticoid receptor density in the hippocampus) were altered by MS, suggesting that an altered HPA axis function may be associated to behavioral and cognitive deficits in MS female rats. In addition, MS rats were found to be more vulnerable to chronic stress than controls as shown by decreases in open field activity, increases in immobility time in the forced swim test, and changes in markers of HPA axis (decreases in the density of glucocorticoid receptors). These present findings are discussed in terms of gender differences in adulthood.


Subject(s)
Cognition/physiology , Hypothalamo-Hypophyseal System/physiopathology , Maternal Deprivation , Pituitary-Adrenal System/physiopathology , Stress, Psychological/physiopathology , Animals , Animals, Newborn , Blotting, Western , Female , Hypothalamo-Hypophyseal System/metabolism , In Situ Hybridization , Motor Activity , Pituitary-Adrenal System/metabolism , Rats
18.
Psychopharmacology (Berl) ; 199(1): 1-14, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18470507

ABSTRACT

RATIONALE: Many studies support the validity of the chronic mild stress (CMS) model of depression in rodents. However, most of them focus on analysis of reactivity to rewards during the CMS and/or depressive-like behavior shortly after stress. In this study, we investigate acute and long-term effects of CMS and antidepressant treatment on depressive, anxiety-like behavior and learning. MATERIALS AND METHODS: Mice (C57BL/6) were exposed to CMS for 6 weeks and anhedonia was evaluated by weekly monitoring of sucrose intake. Paroxetine (10 mg kg(-1)day(-1) i.p.) or saline were administered the last 3 weeks of CMS and continued for 2 weeks thereafter. Behavioral tests were performed over the last week of CMS (acute effects) and 1 month later (long-term effects). RESULTS: Mice exposed to CMS displayed both acute and long-term decreased sucrose intake, increased immobility in the forced swimming test (FST) and impaired memory in the novel object recognition test. It is interesting to note that a correlation was found between the cognitive deficits and the helpless behavior in the FST induced by CMS. During the CMS procedure, paroxetine treatment reverted partially recognition memory impairment but failed to prevent the increased immobility in the FST. Moreover, it decreased on its own sucrose intake. Importantly, the long-term effects of CMS were partially prevented by chronic paroxetine. CONCLUSIONS: CMS leads to a long-term altered behavioral profile that could be partially reverted by chronic antidepressant treatment. This study brings novel features regarding the long-term effects of CMS and on the predictive validity of this depression animal model.


Subject(s)
Antidepressive Agents, Second-Generation/pharmacology , Anxiety/psychology , Depression/psychology , Mental Recall/drug effects , Paroxetine/pharmacology , Recognition, Psychology/drug effects , Stress, Psychological/complications , Animals , Drinking/drug effects , Escape Reaction/drug effects , Exploratory Behavior/drug effects , Fear/drug effects , Helplessness, Learned , Injections, Intraperitoneal , Long-Term Care , Male , Mice , Motivation , Motor Activity , Pattern Recognition, Visual/drug effects , Sucrose/administration & dosage , Taste/drug effects
19.
Neuropharmacology ; 54(4): 708-14, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18206183

ABSTRACT

The serotonin 5-HT(6) receptor has become a promising target for the treatment of neuropsychological diseases, such as affective disorders. Increasing evidence implicates stress and its effector system, the hypothalamic-pituitary-adrenal (HPA) axis, in the neurobiology of depression. In addition, there are important memory disturbances in stress-related psychiatric disorders that have been associated to an impairment of the HPA axis reactivity. The aim of the present work is to study the functional interactions between 5-HT(6) receptors and HPA axis. In a situation of increased HPA axis responsiveness (maternal separation, MS) no differences were found in the expression of 5-HT(6) gene in the hippocampus or frontal cortex, although serotonin levels were higher in the frontal cortex of MS rats. 5-HT(6) receptor mRNA expression increased significantly in the hippocampus in a situation of decreased glucocorticoid levels, such as adrenalectomy. Cognitive deficits associated to HPA dysfunction, such those found in the MS model, were fully reversed by administration of SB271046, a selective 5-HT(6) receptor antagonist. A chronic treatment with SB271046 did not modify CRF mRNA levels in the hypothalamus, but there was a higher glucocorticoid receptor density in the hippocampus compared to control. In contrast, in the frontal cortex, treatment with SB271046 induced a significant decrease in glucocorticoid receptor density. These data suggest that expression of 5-HT(6) receptors might be differentially regulated depending on levels of circulating adrenal corticoids. These results are discussed in terms of therapeutical approaches to the treatment of behavioral (depressive-like) and cognitive disturbances associated to an altered response to stress.


Subject(s)
Cognition , Hypothalamo-Hypophyseal System/physiology , Pituitary-Adrenal System/physiology , Receptors, Serotonin/physiology , Acetates/pharmacology , Adrenalectomy/methods , Animals , Behavior, Animal/drug effects , Cognition/drug effects , Corticosterone/metabolism , Corticotropin-Releasing Hormone/genetics , Corticotropin-Releasing Hormone/metabolism , Drug Interactions , Frontal Lobe/drug effects , Frontal Lobe/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Hypothalamo-Hypophyseal System/drug effects , Male , Maternal Deprivation , Morpholines/pharmacology , Neuropsychological Tests , Pituitary-Adrenal System/drug effects , Rats , Rats, Wistar , Receptors, Serotonin/genetics , Serotonin/administration & dosage , Serotonin Antagonists/pharmacology , Sulfonamides/pharmacology , Thiophenes/pharmacology
20.
Cytogenet Genome Res ; 122(3-4): 237-42, 2008.
Article in English | MEDLINE | ID: mdl-19188692

ABSTRACT

Nuclear functions are strongly dependent on the three-dimensional organization of the interphase nucleus. Given the importance of telomeres in the behaviour and stability of chromosomes, we have investigated the architecture of the human nucleus from the telomere perspective by 3D-FISH and laser confocal microscopy. We observed a randomly scattered telomere distribution in all confocal sections of the interphase nuclear volume with various levels of telomere clustering in different cell types. This distribution is independent of H2AX presence or phosphorylation status. We also observed that telomeres usually cluster at the periphery of the nucleolus following its cell cycle dependent dynamic formation but are never present in the interior of the nucleolus. These perinucleolar telomeric clusters contain the telomeres of the short arms of acrocentric chromosomes, explaining the p-arm association of acrocentric chromosomes frequently found in metaphase. Thus, chromosome positioning in metaphase spreads is tightly connected to the three-dimensional architecture of the interphase nucleus.


Subject(s)
Cell Nucleolus/physiology , Cell Nucleus/ultrastructure , Telomere/ultrastructure , Animals , Cell Nucleolus/ultrastructure , Chromosomes, Human, Pair 18/ultrastructure , Fibroblasts/cytology , Fibroblasts/physiology , Histones/deficiency , Histones/genetics , Humans , In Situ Hybridization, Fluorescence , Interphase , Lymphocytes/cytology , Lymphocytes/physiology , Mice , Mice, Knockout , Microscopy, Confocal/methods , Telomere/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...